美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
51662-1399-1	51662-1399	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HCI AND EPINEPHRINE	BUPIVACAINE HCI AND EPINEPHRINE	INJECTION, SOLUTION	PERINEURAL	20191209	N/A	ANDA	ANDA070968	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5 mg/mL; .005 mg/mL	50 mL in 1 VIAL, MULTI-DOSE (51662-1399-1)
51662-1399-2	51662-1399	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HCI AND EPINEPHRINE	BUPIVACAINE HCI AND EPINEPHRINE	INJECTION, SOLUTION	PERINEURAL	20210126	N/A	ANDA	ANDA070968	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5 mg/mL; .005 mg/mL	1 VIAL, MULTI-DOSE in 1 POUCH (51662-1399-2) / 50 mL in 1 VIAL, MULTI-DOSE
51662-1399-3	51662-1399	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HCI AND EPINEPHRINE	BUPIVACAINE HCI AND EPINEPHRINE	INJECTION, SOLUTION	PERINEURAL	20210126	N/A	ANDA	ANDA070968	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5 mg/mL; .005 mg/mL	25 POUCH in 1 CASE (51662-1399-3) / 1 VIAL, MULTI-DOSE in 1 POUCH / 50 mL in 1 VIAL, MULTI-DOSE
63323-463-57	63323-463	HUMAN PRESCRIPTION DRUG	SENSORCAINE	BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	PERINEURAL	20101119	N/A	ANDA	ANDA070968	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5 mg/mL; .005 mg/mL	25 VIAL, MULTI-DOSE in 1 TRAY (63323-463-57) / 50 mL in 1 VIAL, MULTI-DOSE (63323-463-01)